


Company Information
Ask for more detail from the seller
Contact SupplierSURGISPON® adheres to the bleeding site and absorbsapproximately 45 times of its own weight of blood. It has aporous structure which activates the thrombocytes at themoment blood comes in contact with the matrix of thesponge. This causes the thrombocytes to release a series ofsubstances which promote their aggregation. At the sametime as their surface characterictic change, enabling themto act as a catalyst for the formation of the fibrin, whichstops the bleeding. When implanted in the tissues, it iscompletely absorbed within

